Because retatrutide remains investigational, I recommend that patients discuss potential side effects with a qualified medical professional and avoid using products marketed outside legitimate clinical trial settings
CMS had proposed a rule change in late 2024 that would have allowed Medicare Part D to cover weight loss drugs starting with plan year 2026
Consider Limitations: Its important to note that BAC calculators provide rough estimates and may not account for individual variations in alcohol metabolism, tolerance, or other factors that can affect BAC levels
None of them are good
Although our data align with the notion that inhibiting NMDA receptor signalling in the hypothalamus decreases food intake and body weight 8,40 , earlier studies have demonstrated that NMDA receptor antagonism in the brainstem attenuates vagus-mediated meal-related satiety 6,7,42
de Boer IH, Rue TC, Hall YN, et al